Can serum L-lactate, D-lactate, creatine kinase and I-FABP be used as diagnostic markers in critically ill patients suspected for bowel ischemia
| Autor: | Ilse van Stijn, Peter H. J. van der Voort, Berit Westra, Saskia Rijkenberg, Rob J. Bosman, Ference J Loupatty, Jos P.J. Wester, Inez-Anne Haagen |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Male
medicine.medical_specialty LDH Critical Illness Ischemia Colonoscopy Intensivist Autopsy Fatty Acid-Binding Proteins Gastroenterology Cohort Studies chemistry.chemical_compound I-FABP Intensive care Lactate dehydrogenase Anesthesiology Internal medicine ALAT Medicine Humans Lactic Acid Prospective Studies Creatine kinase Intestinal Mucosa Critically ill Aged Intestinal ischemia medicine.diagnostic_test biology business.industry Middle Aged L-lactate medicine.disease Bowel Surgery Intestines Anesthesiology and Pain Medicine chemistry biology.protein Female business D-lactate Biomarkers Research Article |
| Zdroj: | BMC Anesthesiology |
| ISSN: | 1471-2253 |
| Popis: | Background The prognostic value of biochemical tests in critically ill patients with multiple organ failure and suspected bowel ischemia is unknown. Methods In a prospective observational cohort study intensive care patients were included when the attending intensivist considered intestinal ischemia in the diagnostic workup at any time during intensive care stay. Patients were only included once. When enrolment was ended each patient was classified as ‘proven intestinal ischemia’, ‘ischemia likely’, ‘ischemia unlikely’ or ‘no intestinal ischemia’. Proven intestinal ischemia was defined as the gross disturbance of blood flow in the bowel, regardless of extent and grade. Classification was based on reports from the operating surgeon, pathology department, endoscopy reports and CT-scan. Lactate dehydrogenase (LDH), creatine kinase (CK), alanine aminotransferase (ALAT), L-lactate were available for the attending physician. D-lactate and intestinal fatty acid binding protein (I-FABP) were analysed later in a batch. I-FABP was only measured in patients with proven ischemia or no ischemia. Results For 44 of the 120 included patients definite diagnostic studies were available. 23/44 patients (52%) had proven intestinal ischemia as confirmed by surgery, colonoscopy, autopsy and/or histopathological findings. LDH in these patients was 285 U/l (217–785) vs 287 U/l (189–836) in no-ischemia; p = 0.72. CK was 226 U/l in patients with proven ischemia (126–2145) vs 347 U/l (50–1427), p = 0.88. ALAT was 53 U/l (18–300) vs 34 U/l (14–34), p-0,56. D-lactate 0.41 mmol/l (0.11-0.75) vs 0.56 mmol/l (0.27-0.77), p = 0.46. L-lactate 3.5 mmol/l (2.2-8.4) vs 2.6 mmol/l (1.7-3.9), p = 0.09. I-FABP 2872 pg/ml (229–4340) vs 1020 pg/ml (239–5324), p = 0.98. Patient groups proven and likely ischemia together compared to unlikely and no-ischemia together showed significant higher L-lactate (p = 0.001) and higher D-lactate (p = 0.003). Conclusions Measurement of LDH, CK, and ALAT did not discriminate critically ill patients with proven intestinal ischemia from those with definite diagnosis no-ischemia. However, L-lactate and D-lactate levels were higher in patients with proven or likely ischemia and need further study just as I-FABP. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink